Total Payments
$16,418
2024 Payments
$5,622
Companies
17
Transactions
52
Medicare Patients
1,156
Medicare Billing
$206,594
Payment Breakdown by Category
Consulting$10,140 (61.8%)
Food & Beverage$3,862 (23.5%)
Travel$2,400 (14.6%)
Education$16.89 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,140 | 2 | 61.8% |
| Food and Beverage | $3,862 | 44 | 23.5% |
| Travel and Lodging | $2,400 | 5 | 14.6% |
| Education | $16.89 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alnylam Pharmaceuticals Inc. | $8,716 | 10 | $0 (2019) |
| CALLIDITAS THERAPEUTICS US INC. | $5,063 | 9 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $437.81 | 6 | $0 (2023) |
| Mallinckrodt LLC | $349.46 | 4 | $0 (2018) |
| Bayer Healthcare Pharmaceuticals Inc. | $340.08 | 3 | $0 (2023) |
| Travere Therapeutics, Inc. | $281.94 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $269.95 | 3 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $138.86 | 2 | $0 (2023) |
| AKEBIA THERAPEUTICS INC | $125.00 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $122.66 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,622 | 17 | CALLIDITAS THERAPEUTICS US INC. ($5,063) |
| 2023 | $380.89 | 4 | Alexion Pharmaceuticals, Inc. ($121.60) |
| 2022 | $475.79 | 5 | Bayer HealthCare Pharmaceuticals Inc. ($228.30) |
| 2021 | $406.25 | 4 | Alexion Pharmaceuticals, Inc. ($158.59) |
| 2020 | $95.02 | 1 | Otsuka America Pharmaceutical, Inc. ($95.02) |
| 2019 | $9,089 | 17 | Alnylam Pharmaceuticals Inc. ($8,716) |
| 2018 | $225.81 | 2 | Mallinckrodt LLC ($225.81) |
| 2017 | $123.65 | 2 | Mallinckrodt LLC ($123.65) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $54.48 | General |
| Category: Nephrology | ||||||
| 12/06/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $39.11 | General |
| 12/05/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $97.99 | General |
| 10/26/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $52.58 | General |
| 10/25/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $159.52 | General |
| Category: Nephrology | ||||||
| 10/23/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Nephrology | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $80.96 | General |
| 10/01/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Nephrology | ||||||
| 10/01/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $52.42 | General |
| Category: Nephrology | ||||||
| 09/27/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $1,105.06 | General |
| Category: Nephrology | ||||||
| 09/27/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $360.00 | General |
| Category: Nephrology | ||||||
| 09/26/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $100.65 | General |
| Category: Nephrology | ||||||
| 07/15/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $124.68 | General |
| Category: Nephrology | ||||||
| 05/09/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $127.95 | General |
| 04/30/2024 | Baxter Healthcare | — | Food and Beverage | In-kind items and services | $18.76 | General |
| 02/26/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $106.30 | General |
| Category: Nephrology | ||||||
| 01/23/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 11/03/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $43.84 | General |
| Category: NEPHROLOGY | ||||||
| 10/25/2023 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $103.67 | General |
| Category: Nephrology | ||||||
| 05/03/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $121.60 | General |
| 02/10/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $111.78 | General |
| Category: Cardio-renal | ||||||
| 11/18/2022 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.38 | General |
| 10/05/2022 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $103.68 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 09/16/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $110.91 | General |
| Category: Cardio-renal | ||||||
| 06/14/2022 | E.R. Squibb & Sons, L.L.C. | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $121.43 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 254 | 444 | $173,327 | $57,923 |
| 2022 | 7 | 263 | 418 | $102,667 | $33,654 |
| 2021 | 9 | 272 | 461 | $151,750 | $56,345 |
| 2020 | 11 | 367 | 592 | $166,752 | $58,671 |
Total Patients
1,156
Total Services
1,915
Medicare Billing
$206,594
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 14 | 99 | $82,082 | $27,982 | 34.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 59 | 101 | $25,837 | $9,664 | 37.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 49 | 52 | $22,714 | $7,169 | 31.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 57 | 86 | $14,910 | $5,470 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 56 | $16,828 | $4,980 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 18 | 20 | $5,280 | $1,007 | 19.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 11 | 16 | $2,684 | $917.76 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 14 | $2,992 | $732.60 | 24.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 56 | 107 | $25,549 | $8,853 | 34.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 49 | 51 | $23,588 | $7,917 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 67 | $20,383 | $6,434 | 31.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 55 | 102 | $16,905 | $5,832 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 19 | 24 | $6,194 | $1,308 | 21.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 13 | 23 | $3,887 | $1,304 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 18 | $3,867 | $1,197 | 30.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 23 | 26 | $2,294 | $809.62 | 35.3% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 13 | 80 | $55,586 | $23,482 | 42.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 67 | 125 | $30,493 | $10,475 | 34.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 56 | 60 | $28,550 | $9,862 | 34.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 44 | $12,028 | $4,457 | 37.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 53 | 73 | $12,482 | $4,160 | 33.3% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 15 | 24 | $4,152 | $1,444 | 34.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 16 | 18 | $4,680 | $1,006 | 21.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 18 | 25 | $2,303 | $786.18 | 34.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 11 | 12 | $1,476 | $673.80 | 45.7% |
About Jie Tang, MD, MS, MPH
Jie Tang, MD, MS, MPH is a Nephrology healthcare provider based in Riverside, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1871583997.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jie Tang, MD, MS, MPH has received a total of $16,418 in payments from pharmaceutical and medical device companies, with $5,622 received in 2024. These payments were reported across 52 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($10,140).
As a Medicare-enrolled provider, Tang has provided services to 1,156 Medicare beneficiaries, totaling 1,915 services with total Medicare billing of $206,594. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology, Nephrology
- Location Riverside, RI
- Active Since 10/28/2005
- Last Updated 09/14/2016
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1871583997
Products in Payments
- TARPEYO (Drug) $5,063
- ACTHAR (Biological) $349.46
- Kerendia (Drug) $340.08
- JYNARQUE (Drug) $138.86
- Auryxia (Drug) $125.00
- LOKELMA (Drug) $125.00
- BENLYSTA (Biological) $122.66
- Pomalyst (Drug) $121.43
- Crysvita (Drug) $103.68
- Parsabiv (Drug) $103.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Riverside
Reginald Gohh, Md, MD
Nephrology — Payments: $65,346
Nephrology $65,346
Douglas Shemin, Md, MD
Nephrology — Payments: $36,310
Nephrology $36,310
Dr. Ankur Shah, M.d, M.D
Nephrology — Payments: $26,029
Nephrology $26,029
Joseph Lee, M.d, M.D
Nephrology — Payments: $18,723
Nephrology $18,723
Dr. Dalia Zaky Dawoud, Md, MD
Nephrology — Payments: $11,089
Nephrology $11,089
Salam Ishak, M.d, M.D
Nephrology — Payments: $5,994
Nephrology $5,994